Free Trial
TSE:HSM

Helius Medical Technologies (HSM) Stock Price, News & Analysis

C$18.35
-0.32 (-1.71%)
(As of 09/9/2021)

About Helius Medical Technologies Stock (TSE:HSM)

Key Stats

Today's Range
C$18.35
C$18.48
50-Day Range
C$18.35
C$18.35
52-Week Range
C$14.26
C$40.00
Volume
930 shs
Average Volume
3,578 shs
Market Capitalization
C$42.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Receive HSM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

HSM Stock News Headlines

I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

HSM Stock Analysis - Frequently Asked Questions

Helius Medical Technologies' stock was trading at C$18.35 at the beginning of the year. Since then, HSM shares have increased by 0.0% and is now trading at C$18.35.
View the best growth stocks for 2024 here
.

Shares of HSM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include Athabasca Oil (ATH), VanEck Junior Gold Miners ETF (GDXJ), Suncor Energy (SU), Teck Resources (TECK.B), Whitecap Resources (WCP), Air Canada (AC) and Black Iron (BKI).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$477,000.00
Cash Flow
C$3.21 per share
Book Value
C$3.61 per share

Miscellaneous

Free Float
N/A
Market Cap
C$42.54 million
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (TSE:HSM) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners